Hemoglobin Oxygen Therapeutics LLC (HOTI)
Hemoglobin Oxygen Therapeutics LLC will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

HOTI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year Ending
Current Dec '21 Dec '20
Debt / Equity Ratio
-1.00-1.00-1.47
Debt / EBITDA Ratio
-1.48-1.48-2.52
Debt / FCF Ratio
-4.81-4.81-8.79
Quick Ratio
0.030.030.05
Return on Equity (ROE)
66.24%66.24%61.25%
Return on Assets (ROA)
-101.51%-101.51%-50.81%
Return on Capital (ROIC)
8263.84%8263.84%-115.76%
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).